Skip to main content
Journal cover image

Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trial.

Publication ,  Journal Article
Barbagelata, A; Di Carli, MF; Califf, RM; Garg, J; Birnbaum, Y; Grinfeld, L; Gibbons, RJ; Granger, CB; Goodman, SG; Wagner, GS; Mahaffey, KW ...
Published in: Am Heart J
October 2005

BACKGROUND: Noninvasive methods are needed to evaluate reperfusion success in patients with acute myocardial infarction (MI). The AMISTAD trial was analyzed to compare MI size and myocardial salvage determined by electrocardiogram (ECG) with technetium Tc 99m sestamibi single-photon emission computerized tomography (SPECT) imaging. METHODS: Of 236 patients enrolled in AMISTAD, 166 (70 %) with no ECG confounding factors and no prior MI were included in this analysis. Of these, group 1 (126 patients, 53%) had final infarct size (FIS) available by both ECG and SPECT. Group 2 (56 patients, 24%) had myocardium at risk, FIS, and salvage index (SI) assessed by both SPECT and ECG techniques. Aldrich/Clemmensen scores for myocardium at risk and the Selvester QRS score for final MI size were used. Salvage index was calculated as follows: SI = (myocardium at risk-FIS)/(myocardium at risk). RESULTS: In group 1, FIS was 15% (6, 24) as measured by ECG and 11% (2, 27) as measured by SPECT. In the adenosine group, FIS was 12% (6, 21) and 11% (2, 22). In the placebo group, FIS was 16.5% (7.5, 24) and 11.5% (3.0, 38.5) by ECG and SPECT, respectively. The overall correlation between SPECT and ECG for FIS was 0.58 (P = .0001): 0.60 in the placebo group (P = .0001) and 0.54 (P = .0001) in the adenosine group. In group 2, myocardium at risk was 23% (17, 30) and 26% (10, 50) with ECG and SPECT, respectively (P = .0066). Final infarct size was 17% (6, 21) and 12% (1, 24) (P < .0001). The SI was 29% (-7, 57) and 46% (15, 79) with ECG and SPECT, respectively (P = .0510). CONCLUSIONS: The ECG measurement of infarct size has a moderate relationship with SPECT infarct size measurements in the population with available assessments. This ECG algorithm must further be validated on clinical outcomes.

Duke Scholars

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

October 2005

Volume

150

Issue

4

Start / End Page

659 / 665

Location

United States

Related Subject Headings

  • Thrombolytic Therapy
  • Prospective Studies
  • Myocardial Infarction
  • Humans
  • Electrocardiography
  • Cardiovascular System & Hematology
  • Adenosine
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Barbagelata, A., Di Carli, M. F., Califf, R. M., Garg, J., Birnbaum, Y., Grinfeld, L., … AMISTAD Investigators. (2005). Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trial. Am Heart J, 150(4), 659–665. https://doi.org/10.1016/j.ahj.2004.10.014
Barbagelata, Alejandro, Marcelo F. Di Carli, Robert M. Califf, Jyotsna Garg, Yochai Birnbaum, Liliana Grinfeld, Raymond J. Gibbons, et al. “Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trial.Am Heart J 150, no. 4 (October 2005): 659–65. https://doi.org/10.1016/j.ahj.2004.10.014.
Barbagelata A, Di Carli MF, Califf RM, Garg J, Birnbaum Y, Grinfeld L, et al. Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trial. Am Heart J. 2005 Oct;150(4):659–65.
Barbagelata, Alejandro, et al. “Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trial.Am Heart J, vol. 150, no. 4, Oct. 2005, pp. 659–65. Pubmed, doi:10.1016/j.ahj.2004.10.014.
Barbagelata A, Di Carli MF, Califf RM, Garg J, Birnbaum Y, Grinfeld L, Gibbons RJ, Granger CB, Goodman SG, Wagner GS, Mahaffey KW, AMISTAD Investigators. Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trial. Am Heart J. 2005 Oct;150(4):659–665.
Journal cover image

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

October 2005

Volume

150

Issue

4

Start / End Page

659 / 665

Location

United States

Related Subject Headings

  • Thrombolytic Therapy
  • Prospective Studies
  • Myocardial Infarction
  • Humans
  • Electrocardiography
  • Cardiovascular System & Hematology
  • Adenosine
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology